Pretomanid
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 397 publications
Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB.
Journal: Journal of clinical microbiology
Published: January 12, 2026
Delamanid and pretomanid have comparable bactericidal activity but pretomanid potently inhibits Mycobacterium tuberculosis ribosomal rRNA synthesis.
Journal: bioRxiv : the preprint server for biology
Published: January 09, 2026
The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management.
Journal: Clinical microbiology reviews
Published: January 07, 2026
Pretomanid: The life-saving drug to combat Pakistan's TB crisis.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: December 11, 2025
Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database.
Journal: BMJ open
Published: December 08, 2025
Tracking the evolution of an extensively drug-resistant cross-border Mycobacterium tuberculosis cluster, Europe, January 2016 up to August 2025: implications for European surveillance.
Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: November 21, 2025
Exploring the anti-tuberculosis activity mechanism of OTB-658: Multi-omics analysis.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 04, 2025
Effectiveness and safety of the BPaL regimen in the Philippines.
Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: October 28, 2025
Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.
Journal: Open forum infectious diseases
Published: October 01, 2025
Sterilizing activity of spectinamide MBX-4888A when replacing linezolid in the Nix-TB regimen in the relapsing BALB/c mouse model of tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: September 30, 2025
In vitro exposure to clofazimine can select for delamanid and pretomanid resistance in Mycobacterium tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: September 22, 2025
Deconvoluting drug interactions using M. tuberculosis physiologic processes: transcriptional disaggregation of the BPaL regimen in vivo.
Journal: Antimicrobial agents and chemotherapy
Published: September 18, 2025
Last Updated: 02/24/2026